{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:47:52Z","timestamp":1791388072019,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY15H090013"],"award-info":[{"award-number":["LY15H090013"]}]},{"name":"Project of Public Welfare Technology and Applications of Lishui","award":["2016GYX26"],"award-info":[{"award-number":["2016GYX26"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.arr.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T13:28:58Z","timestamp":1551360538000},"page":"55-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies"],"prefix":"10.1016","volume":"51","author":[{"given":"Futao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2019.02.006_bib0005","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/aje\/kwn005","article-title":"How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?","volume":"167","author":"Bekkering","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"643","key":"10.1016\/j.arr.2019.02.006_bib0010","article-title":"Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis","volume":"14","author":"Beydoun","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.arr.2019.02.006_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11239-012-0856-x","article-title":"Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer\u2019s disease","volume":"36","author":"Cacciapuoti","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.arr.2019.02.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5912146","article-title":"Folic acid supplementation mitigates Alzheimer\u2019s disease by reducing inflammation: a randomized controlled trial","volume":"2016","author":"Chen","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.arr.2019.02.006_bib0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","article-title":"Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease","volume":"55","author":"Clarke","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2019.02.006_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/539156a","article-title":"How to defeat dementia","volume":"539","author":"Dolgin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.arr.2019.02.006_bib0035","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2019.02.006_bib0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ana.10440","article-title":"Homocysteine, white matter hyperintensities, and cognition in healthy elderly people","volume":"53","author":"Dufouil","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2019.02.006_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2007.07.005","article-title":"Cardiovascular risk factors and homocysteine in epilepsy","volume":"76","author":"Elliott","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.arr.2019.02.006_bib0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.2011.242446","article-title":"Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia","volume":"83","author":"Ford","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2019.02.006_bib0055","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","article-title":"Methods for trend estimation from summarized dose-response data, with applications to meta-analysis","volume":"135","author":"Greenland","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.arr.2019.02.006_bib0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/ajcn\/85.2.511","article-title":"Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging","volume":"85","author":"Haan","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.arr.2019.02.006_bib0065","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1017\/S1041610213001294","article-title":"Homocysteine levels and dementia risk in Yoruba and African Americans","volume":"25","author":"Hendrie","year":"2013","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.arr.2019.02.006_bib0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e3181f88162","article-title":"Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study","volume":"75","author":"Hooshmand","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2019.02.006_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.amjmed.2004.08.019","article-title":"Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging","volume":"118","author":"Kado","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.arr.2019.02.006_bib0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/oxfordjournals.aje.a010000","article-title":"Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study","volume":"150","author":"Kalmijn","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.arr.2019.02.006_bib0085","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1468-1331.2009.02590.x","article-title":"Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study","volume":"16","author":"Kivipelto","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2019.02.006_bib0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3389\/fnins.2016.00538","article-title":"Role of homocysteine in the ischemic stroke and development of ischemic tolerance","volume":"10","author":"Lehotsky","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2019.02.006_bib0095","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/01.WNL.0000129504.60409.88","article-title":"Plasma homocysteine levels and risk of Alzheimer disease","volume":"62","author":"Luchsinger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2019.02.006_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8","article-title":"Total serum homocysteine in senile dementia of Alzheimer type","volume":"13","author":"McCaddon","year":"1998","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2019.02.006_bib0105","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jamda.2017.05.008","article-title":"One-carbon metabolism biomarkers and cognitive decline in the very old: the newcastle 85+ study","volume":"18","author":"Mendonca","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.arr.2019.02.006_bib0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-150458","article-title":"Increased total homocysteine levels predict the risk of incident dementia independent of cerebral small-vessel diseases and vascular risk factors","volume":"49","author":"Miwa","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2019.02.006_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000363054","article-title":"Hyperhomocysteinemia and risk of cognitive decline: a meta-analysis of prospective cohort studies","volume":"72","author":"Nie","year":"2014","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2019.02.006_bib0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/ana.20645","article-title":"Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study","volume":"58","author":"Nurk","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2019.02.006_bib0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwr265","article-title":"Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software","volume":"175","author":"Orsini","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.arr.2019.02.006_bib0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.arr.2019.02.006_bib0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-148-6-200803180-00005","article-title":"Prevalence of cognitive impairment without dementia in the United States","volume":"148","author":"Plassman","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2019.02.006_bib0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ajcn\/82.3.636","article-title":"Homocysteine and folate as risk factors for dementia and Alzheimer disease","volume":"82","author":"Ravaglia","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.arr.2019.02.006_bib0145","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.neurobiolaging.2006.08.012","article-title":"Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging","volume":"28","author":"Ravaglia","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2019.02.006_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000182421","article-title":"Plasma homocysteine and risk of mild cognitive impairment","volume":"27","author":"Reitz","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2019.02.006_bib0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000441565","article-title":"Lowered levels of carbonyl proteins after vitamin B supplementation in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"16","author":"Rommer","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2019.02.006_bib0160","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(18)30338-7","article-title":"Nutrition and prevention of cognitive impairment","volume":"17","author":"Scarmeas","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2019.02.006_bib0165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2019.02.006_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","article-title":"Homocysteine, B vitamins, and cognitive impairment","volume":"36","author":"Smith","year":"2016","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.arr.2019.02.006_bib0175","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2019.02.006_bib0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.archger.2008.03.009","article-title":"Hyperhomocysteinemia and Alzheimer\u2019s disease: a systematic review","volume":"48","author":"Van Dam","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.arr.2019.02.006_bib0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jalz.2010.08.234","article-title":"Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants","volume":"7","author":"Wald","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2019.02.006_bib0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00394-013-0526-6","article-title":"Homocysteine, antioxidant micronutrients and late onset dementia","volume":"53","author":"Whalley","year":"2014","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.arr.2019.02.006_bib0195","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1097\/MD.0000000000000759","article-title":"Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies","volume":"94","author":"Xu","year":"2015","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.arr.2019.02.006_bib0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/nu7010074","article-title":"Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis","volume":"7","author":"Yang","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2019.02.006_bib0205","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2019.02.006_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2017.03.013","article-title":"The bridging integrator 1 Gene rs7561528 polymorphism contributes to Alzheimer\u2019s disease susceptibility in East Asian and Caucasian populations","volume":"469","author":"Zhou","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2019.02.006_bib0215","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neurobiolaging.2009.02.024","article-title":"Midlife homocysteine and late-life dementia in women. A prospective population study","volume":"32","author":"Zylberstein","year":"2011","journal-title":"Neurobiol. Aging"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163718302873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163718302873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T07:58:55Z","timestamp":1552809535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163718302873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":43,"alternative-id":["S1568163718302873"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2019.02.006","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}